Evidence map›Paper›PMID 34517344›Full record

ArticleAging2021

Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways.

Yu Liu, Yan-Qing Li, Shi-Hao Huang, Yong-Long Li, Jia-Wei Xia, Jun-Shuang Jia, Fang Wei, Jia-Hong Wang, Guan-Qi Dai, Yu-Cai Wang and 7 more

Open access · greenAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Recent advances on the role of G0S2.Discover oncology · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Yu LiuCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Yan-Qing LiDepartment of Hematology, Central Hospital of Xuhui District, Shanghai 200030, China.
Shi-Hao HuangCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Yong-Long LiCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Jia-Wei XiaThe Third People's Hospital of Kunming (The Sixth Affiliated Hospital of Dali University), Kunming 650041, China.
Jun-Shuang JiaCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Fang WeiCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Jia-Hong WangCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Guan-Qi DaiCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Yu-Cai WangCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Xiao-Yan LiCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Liu-Xin HanThe Third People's Hospital of Kunming (The Sixth Affiliated Hospital of Dali University), Kunming 650041, China.
Xiao-Ling ZhangDepartment of Physiology, Faculty of Basic Medical Sciences, Guilin Medical University, Guilin 541004, China.
Xu-Dong XiangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming 650118, China.
Wen-Tao ZhaoDepartment of Gastrointestinal Oncology, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming 650118, China.
Dong XiaoCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Xiao-Lin LinCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Southern Medical University · CNDali University · CNKunming Medical University · CNGuilin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we investigated the role of embryonic gene Cripto-1 (CR-1) in hepatocellular carcinoma (HCC) using hepatocyte-specific CR-1-overexpressing transgenic mice. The expression of truncated 1.7-kb CR-1 transcript (SF-CR-1) was significantly higher than the full-length 2.0-kb CR-1 transcript (FL-CR-1) in a majority of HCC tissues and cell lines. Moreover, CR-1 mRNA and protein levels were significantly higher in HCC tissues than adjacent normal liver tissues. Hepatocyte-specific over-expression of CR-1 in transgenic mice enhanced hepatocyte proliferation after 2/3 partial hepatectomy (2/3 PHx). CR-1 over-expression significantly increased

Indexed as

AnimalsCarcinogenesisCarcinoma, HepatocellularCell Line, TumorCell ProliferationEpidermal Growth FactorGene Expression RegulationGenetic Predisposition to DiseaseGPI-Linked ProteinsHepatocytesHumansIntercellular Signaling Peptides and ProteinsLiverLiver NeoplasmsMembrane GlycoproteinsMiceEpidermal Growth FactorGPI-Linked ProteinsIntercellular Signaling Peptides and ProteinsMembrane GlycoproteinsNeoplasm ProteinsTDGF1 protein, humanTdgf1 protein, mouseCripto-1 (CR-1)hepatocarcinogenesishepatocellular carcinoma (HCC)transgenic mice

Identifiers

PMID34517344
PMCPMC8457585
OpenAlexW3199742710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.